Exelixis Inc. buy Royal Bank of Canada
Start price
14.05.25
/
50%
€39.53
Target price
14.05.26
€35.75
Performance (%)
-8.65%
Price
13.03.26
€36.11
Summary
This prediction is currently active. With a performance of -8.65%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 14.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | 0.838% | 0.838% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat